Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest Clinical Trials & Medical Discoveries

01 Nov, 2017, 08:00 GMT CALCIVIS Announces Positive Results from PMA Clinical Study Evaluating its Unique CALCIVIS® Imaging System

CALCIVIS, a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, announces positive...


31 Oct, 2017, 16:16 GMT E.U. Funded Research Consortium "LipiDiDiet" Finds a way to Impact Alzheimer's Disease Before it's too Late: Data Published in The Lancet Neurology

Full results from the European LipiDiDiet clinical trial were published online today in The Lancet...


31 Oct, 2017, 08:00 GMT Atlantis Healthcare Issues White Paper on Enhancing Therapeutic Alliance

Atlantis Healthcare Ltd., the global leader in patient self-management and behavior change programs, today releases its latest White Paper...


31 Oct, 2017, 04:35 GMT Astute Medical Highlights Clinical Presentations And Activities At Kidney Week 2017

Astute Medical, Inc., developer of biomarkers for better healthcare, today previewed several presentations taking place in conjunction with the...


31 Oct, 2017, 04:00 GMT Daiichi Sankyo Announces ENLIVEN Phase 3 Study of Pexidartinib Met Primary Endpoint in Tenosynovial Giant Cell Tumor

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced today that the pivotal phase 3 placebo-controlled ENLIVEN (NCT02371369) study...


30 Oct, 2017, 23:01 GMT Long-term Aspirin use Reduces the Incidence of Digestive Cancers by up to 47%, Study Presented at UEG Week Reveals

The long-term use of aspirin has been shown to significantly reduce the incidence of digestive cancers, new research presented today at the 25th...


30 Oct, 2017, 18:15 GMT OrbusNeich's COMBO™ Dual Therapy Stent Demonstrates Non-inferiority vs the Market Leading XIENCE™ Everolimus Eluting Stent

One-year results from the pivotal HARMONEE trial reported at TCT 2017 New results from the HARMONEE Japan/US Registration Trial, reported by...


30 Oct, 2017, 17:20 GMT Analysis of Landmark Study Showed Patients Treated for Left-Main Coronary Artery Disease with XIENCE Stent Felt Better Faster and Had Similar Long-Term Outcomes to Open-Heart Surgery

- Long-term health and quality of life were similar at three years for patients receiving a XIENCE stent and patients who underwent surgery -...


30 Oct, 2017, 12:30 GMT Launch of New Advanced Breast Cancer (ABC) Global Charter

A multi-stakeholder initiative setting out 10 goals to change the future of advanced breast cancer by 2025 The Advanced Breast Cancer (ABC)...


30 Oct, 2017, 11:00 GMT UCLA Team Reports Positive Topline Results from Double-Blind Trial of NeuroSigma's Non-Invasive eTNS System for Treatment of Pediatric ADHD

Primary and secondary endpoints statistically significant NeuroSigma, Inc. (NeuroSigma) today announced that on Friday, October 27, 2017, at...


30 Oct, 2017, 09:00 GMT OBI Pharma announces OBI-3424 results from the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Study finds OBI-3424 exerts profound in vivo efficacy and safety against patient-derived xenograft (PDX) models of T-cell acute lymphoblastic...


30 Oct, 2017, 04:01 GMT ReCor Medical Announces 1000th Enrollment and 150th Randomization in RADIANCE-HTN Hypertension Study

ReCor Medical announced progress milestones in the study of its Paradise® Renal Denervation System as a potential treatment for hypertension,...


27 Oct, 2017, 09:00 BST FRANKL Pharma Brings 'Miraculous' Treatment to UK for Psoriasis Awareness Week

One of Britain's most respected dermatologists has hailed as 'miraculous' a non-steroid treatment for psoriasis following its first efficacy...


27 Oct, 2017, 08:00 BST Kyowa Hakko Kirin Announces Marketing Authorisation Application for Mogamulizumab Validated by European Medicines Agency

Kyowa Hakko Kirin Co., Ltd. (Tokyo: 4151 President and CEO: Nobuo Hanai, "Kyowa Hakko Kirin") today announces that its marketing authorisation...


27 Oct, 2017, 08:00 BST Prequalified by WHO: SumiShield® 50WG - a new Mode of Action Chemistry for use in the Fight Against Malaria Transmitting Mosquitoes

- New active ingredient, Clothianidin, used for the first time in vector control - Single mode of action chemistry for effective...


27 Oct, 2017, 08:00 BST Enterome's EB8018, a First-in-class Drug Candidate Targeting Crohn's Disease, Successfully Completes Phase I Study in Healthy Volunteers

ENTEROME SA, a pioneer of innovative therapies for microbiome-related diseases, is pleased to announce the successful completion of the first...


27 Oct, 2017, 07:00 BST Proton Across the Membrane: NUST MISIS Physicists Demystify Biochemical Mechanism of Proton Transport in Mitochondria

Microbiologists and biophysicists from NUST MISIS and scientists from the Johannes Kepler University have managed to answer some major...


26 Oct, 2017, 15:45 BST Global Cancer Janus Kinase Inhibitors Market Opportunity & Clinical Trial Insight 2023

As per report findings, janus kinase inhibitors have emerged as one of the new potential candidate and growth frontier for the various stake...


26 Oct, 2017, 15:08 BST HLT, Inc. to Provide Clinical Update at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) Conference

RADIANT clinical study is evaluating safety and performance outcomes of the Meridian® Valve and Pathfinder® II Delivery System for severe aortic...


26 Oct, 2017, 14:54 BST Stryker Highlights Importance of Recognizing Stroke Signs for World Stroke Day

In honor of World Stroke Day, Stryker reminds the public about the importance of recognizing the signs of a stroke. During a stroke, 1.9 million...


26 Oct, 2017, 14:45 BST United States Pediatric Vaccine Market 2017 - Demand, Insights, Analysis, Opportunities Segmentation and Forecast to 2024

United States Pediatric Vaccine market is likely to reach nearly US$ 10 Billion by 2024. Growth in US pediatric vaccine market can be attributed...


26 Oct, 2017, 07:00 BST CeloNova's COBRA PzF NanoCoated Coronary Stent (NCS) Being Studied with 14-day DAPT in High Bleeding Risk Patients

COBRA REDUCE Trial to be Highlighted at TCT Conference in Denver, Colorado CeloNova BioSciences, Inc. (CeloNova), a global medical device...


25 Oct, 2017, 14:00 BST INSIGHTEC Receives FDA Approval to Initiate Pivotal Study of Exablate Neuro for the Treatment of Patients with Parkinson's Disease

INSIGHTEC, the world leader of MR-guided Focused Ultrasound announced today that it has received approval from the U.S. Food and Drug...


24 Oct, 2017, 15:25 BST Alligator Bioscience Aptevo Therapeutics: Tumor Antigen 5T4 Associated with Many Forms of Solid Tumors Identified as the Second Target for ALG.APV-527

Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy...


24 Oct, 2017, 13:30 BST Frost & Sullivan Applauds GenePOC's Commitment to Advancing Molecular Diagnostics through Technological Leadership and Patient-centric Innovation

GenePOC's multifactorial strategy, as it innovates toward global leadership, expands testing menus tailored to specific geographies Based on...